The Effect of Preoperative Submucosal Administration of Dexamethasone Tramadol Articaine on The Success Rate of Inferior Alveolar Nerve Block on Mandibular Molars With Symptomatic Irreversible Pulpitis A Randomized Double Blind Placebo Controlled Clinical Trial
Phase 4
Completed
- Conditions
- It is difficult to provide complete pulpal anesthesia in mandibular molars with irreversible pulpitis. To establish the effects of submucosal tramadol, dexamethasone, articaine on the success of inferior alveolar nerve block in the endodontic treatment of mandibular molars with symptomatic irreversible pulpitis.endodontic treatmentirreversible pulpitissubmucosal tramadolsubmucosal dexamethasonesubmucosal articaineanesthesic successinferior alveolar nerve block
- Registration Number
- TCTR20210326008
- Lead Sponsor
- /A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
The inclusion criteria included systemically healthy patients, aged between 18 and 65 years, having mandibular molars with symptomatic irreversible pulpitis, preoperative pain score ranging from moderate to severe on a Heft-Parker visual analog scale, radiographically normal periapical area and no pain on percussion.
Exclusion Criteria
The exclusion criteria comprised: pregnant or breastfeeding women, patients with allergy, sensitivity or adverse reactions to the medications administered in this study, those who had taken an analgesic or anti-inflammatory drug within last 12 hours before the treatment, those with unrestorable teeth, teeth with periodontal disease, root resorption, open apex, calcified root canals and pulpal necrosis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method success of pulpal anesthesia During the endodontic treatment HP VAS Scale
- Secondary Outcome Measures
Name Time Method duration of anesthesia ending the anesthesia total time (minutes)